1.A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique.
Antonio PONTORIERO ; Giuseppe IATI ; Stefano PERGOLIZZI
Radiation Oncology Journal 2015;33(3):261-264
External beam radiotherapy can be used to treat cutaneous squamous cell carcinomas (SCC). Acute skin toxicity is the most common adverse event. In this case study we report on an elderly patient with nasal root cutaneous SCC treated with stereotactic technique using a dedicated linear accelerator (CyberKnife system). Grade 3 skin toxicity was observed but it was resolved after 6 weeks. The use of stereotactic radiotherapy permitted a clinical remission of SCC with good cosmetic results.
Aged
;
Carcinoma, Squamous Cell*
;
Humans
;
Particle Accelerators
;
Radiosurgery
;
Radiotherapy
;
Skin
;
Skin Neoplasms
;
Stereotaxic Techniques*
;
Vitamin E
2.Comments on "Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients".
Alessandro SINDONI ; Giuseppe IATÌ ; Antonio PONTORIERO ; Anna SANTACATERINA ; Stefano PERGOLIZZI
Journal of Breast Cancer 2016;19(3):334-335
No abstract available.
Breast Neoplasms*
;
Breast*
;
Recurrence*
;
Risk Factors*
3.Lattice radiotherapy in inflammatory breast cancer: report of a first case treated with curative aim
Silvana PARISI ; Miriam SCIACCA ; Paola CRITELLI ; Giacomo FERRANTELLI ; Federico CHILLARI ; Valeria VENUTI ; Claudio NAPOLI ; Issa SHTEIWI ; Carmelo SIRAGUSA ; Anna BROGNA ; Antonio PONTORIERO ; Gianluca FERINI ; Anna SANTACATERINA ; Stefano PERGOLIZZI
Radiation Oncology Journal 2024;42(2):160-165
Inflammatory breast cancer (IBC) is a rare, aggressive form of breast cancer characterized by poor prognosis. The treatment requires a multidisciplinary approach, with neoadjuvant chemotherapy, surgery, and radiation therapy (RT). Particularly, high doses of conventional RT have been historically delivered in the adjuvant setting after chemotherapy and mastectomy or as radical treatment in patients ineligible for surgery. Here, we report the case of a 49-year-old woman patient with IBC unsuitable for surgery and treated with a combination of lattice RT and fractionated external beam RT concurrent with trastuzumab, with a curative aim. One year after RT, the patient showed a complete response and tolerable toxicities. This is the first reported case of a not-operable IBC patient treated with this particular kind of RT.